ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 55 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $763,000 | -26.6% | 500,000 | 0.0% | 0.12% | -16.9% |
| Q2 2019 | $1,040,000 | +175.1% | 500,000 | +1150.0% | 0.14% | +230.2% |
| Q3 2018 | $378,000 | +600.0% | 40,000 | +81.8% | 0.04% | +207.1% |
| Q4 2016 | $54,000 | -94.8% | 22,000 | -92.7% | 0.01% | -91.7% |
| Q3 2016 | $1,032,000 | -1.1% | 300,000 | 0.0% | 0.17% | -38.0% |
| Q2 2016 | $1,044,000 | -44.4% | 300,000 | -34.0% | 0.27% | -33.4% |
| Q1 2016 | $1,877,000 | -7.2% | 454,500 | 0.0% | 0.41% | +37.5% |
| Q4 2015 | $2,023,000 | -34.2% | 454,500 | -10.0% | 0.30% | -24.5% |
| Q3 2015 | $3,075,000 | – | 505,000 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 260,000 | $866,000 | 0.34% |
| RTW INVESTMENTS, LP | 5,978,355 | $19,908,000 | 0.31% |
| GSA CAPITAL PARTNERS LLP | 309,839 | $1,032,000 | 0.17% |
| QCM Cayman, Ltd. | 12,728 | $42,000 | 0.13% |
| COWEN AND COMPANY, LLC | 486,717 | $1,621,000 | 0.11% |
| Hudson Bay Capital Management LP | 1,400,000 | $4,662,000 | 0.06% |
| Kerrisdale Advisers, LLC | 208,150 | $693,000 | 0.05% |
| Secure Asset Management, LLC | 10,000 | $33,000 | 0.02% |
| PDT Partners, LLC | 72,500 | $241,000 | 0.02% |
| Point72 Asset Management, L.P. | 1,037,700 | $3,456,000 | 0.02% |